Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple drug interactions with phenytoin.

D J Birkett, G G Graham, P M Chinwah

    The Medical Journal of Australia
    |October 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function.

    European journal of clinical pharmacology·2017
    Same author

    Trends in metformin utilisation and dose appropriateness in Australia.

    European journal of clinical pharmacology·2016
    Same author

    Comparing dose prediction software used to manage gentamicin dosing.

    Internal medicine journal·2013
    Same author

    Metformin therapy in patients with chronic kidney disease.

    Diabetes, obesity & metabolism·2012
    Same author

    Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?

    Internal medicine journal·2011
    Same author

    Aurocyanide, dicyano-aurate (I), a pharmacologically active metabolite of medicinal gold complexes.

    Inflammopharmacology·2008
    Same journal

    Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

    The Medical journal of Australia·2026
    Same journal

    Striving for Racial Equity in Oral Cancer Research: A Case Study.

    The Medical journal of Australia·2026
    Same journal

    Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

    The Medical journal of Australia·2026
    Same journal

    Self-Poisoning With Prazosin and Its Off-Label Use in Australia, 2014-2024: Analysis of NSW Poisons Information Centre Data.

    The Medical journal of Australia·2026
    Same journal

    Drivers of Vaccine Uptake for Aboriginal and Torres Strait Islander Children to Inform Tailored Strategies: A Qualitative Study Exploring Health Service Provider Perspective.

    The Medical journal of Australia·2026
    Same journal

    Four Urgent Actions for the Rights to Culturally Safe Breastfeeding for Aboriginal and Torres Strait Islander Mothers and Babies to Breastfeed in Neonatal Intensive Care Environments.

    The Medical journal of Australia·2026
    See all related articles

    Chronic alcoholism can alter phenytoin metabolism, leading to unpredictable drug levels. Discontinuing disulfiram unmasked alcohol-induced enzyme changes, causing phenytoin toxicity and highlighting the need for therapeutic drug monitoring.

    Area of Science:

    • Pharmacology
    • Clinical Toxicology
    • Neuroscience

    Background:

    • Epilepsy management often involves phenytoin, an anticonvulsant drug.
    • Chronic alcoholism is known to affect drug metabolism through enzyme induction.
    • Disulfiram inhibits certain drug-metabolizing enzymes, including those involved in phenytoin breakdown.

    Observation:

    • A patient with epilepsy and chronic alcoholism on phenytoin experienced seizures upon disulfiram withdrawal.
    • Initially, the patient showed resistance to high phenytoin doses, attributed to alcohol-induced metabolic induction.
    • A subsequent small dose increase of phenytoin led to a tenfold rise in plasma concentration and toxicity.

    Findings:

    • Alcohol intake significantly induced phenytoin metabolism, requiring higher doses for therapeutic effect.

    Related Experiment Videos

  • Disulfiram's discontinuation revealed the underlying alcohol-induced enzyme activity.
  • Altered enzyme activity led to a dramatic increase in phenytoin levels and toxicity after a minor dose adjustment.

    • Implications:

    • This case underscores the critical role of alcohol consumption in altering phenytoin pharmacokinetics.
    • Therapeutic drug monitoring of phenytoin plasma concentrations is essential in patients with substance use disorders.
    • Clinicians must consider potential drug-drug and drug-food interactions, especially enzyme inducers/inhibitors, in complex patient cases.